TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 58 filers reported holding TCR2 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,702 | +35.1% | 1,801 | +33.4% | 0.00% | – |
| Q4 2022 | $2,000 | +100.0% | 1,350 | +69.2% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 798 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 798 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -33.3% | 798 | +6.5% | 0.00% | – |
| Q4 2021 | $3,000 | -62.5% | 749 | -16.8% | 0.00% | – |
| Q3 2021 | $8,000 | +33.3% | 900 | +147.9% | 0.00% | – |
| Q2 2021 | $6,000 | +500.0% | 363 | +725.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 44 | +120.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
| MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
| TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
| Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
| K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
| HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
| Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
| Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
| Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
| X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |